Gatifloxacin oral (tablet and suspension) and injection form has been withdrawn from the market, as it has shown incidences of abnormally high or low blood sugar levels in humans. However, its ophthalmic form (eye drop) is available to treat bacterial infections of the eye, which is considered to be safe for use.